Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications

Cancer Research

Volumn 75, Issue 24, 2015, Pages

  Vasudevan, Divya ^a   Hickok, Jason R ^a   Bovee, Rhea C ^a   Pham, Vy ^a   Mantell, Lin L ^b   Bahroos, Neil ^a   Kanabar, Pinal ^a   Cao, Xing Jun ^c   Maienschein Cline, Mark ^a   Garcia, Benjamin A ^c   Thomas, Douglas D ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; HISTONE H3; HISTONE H4; LYSINE; NITRIC OXIDE; NITROGEN OXIDE; HISTONE;

ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LOCUS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MEASUREMENT; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; DNA MICROARRAY; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MASS SPECTROMETRY; NEOPLASMS; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84955447979     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1582     Document Type: Article

References (50)

1. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010;19:698-711. CrossRef Medline Google Scholar
2. Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013;34:503-12. Abstract/FREE Full Text
3. Chang CF, Diers AR, Hogg N. Cancer cell metabolism and the modulating effects of nitric oxide. Free Radic Biol Med 2015;79C:324-36. CrossRef Medline Google Scholar
4. Heinecke JL, Ridnour LA, Cheng RY, Switzer CH, Lizardo MM, Khanna C, et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci U S A 2014;111:6323-8. Abstract/FREE Full Text
5. Hickok JR, Thomas DD. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Des 2010;16:381-91. CrossRef Medline Google Scholar
6. Vasudevan D, Thomas DD. Insights into the diverse effects of nitric oxide on tumor biology. Vitam Horm 2014;96:265-98. CrossRef Medline Google Scholar
7. Zhang Y, Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 2001;15:2343-60. FREE Full Text
8. Re A, Aiello A, Nanni S, Grasselli A, Benvenuti V, Pantisano V, et al. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-beta and endothelial nitric oxide synthase complex. Mol Endocrinol 2011;25:2003-16. CrossRef Medline Google Scholar
9. Gross TJ, Kremens K, Powers LS, Brink B, Knutson T, Domann FE, et al. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol 2014;192:2326-38. Abstract/FREE Full Text
10. Marshall HE, Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J Biol Chem 2002;277:34223-8. Abstract/FREE Full Text
11. Sen N, Snyder SH. Neurotrophin-mediated degradation of histone methyltransferase by S-nitrosylation cascade regulates neuronal differentiation. Proc Natl Acad Sci U S A 2011;108:20178-83. Abstract/FREE Full Text
12. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008;455:411-5. CrossRef Medline Google Scholar
13. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 2008;10:866-73. CrossRef Medline Google Scholar
14. Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S, et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 2008;105:19183-7. Abstract/FREE Full Text
15. Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, et al. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer 2013;132:9-18. CrossRef Medline Google Scholar
16. Hickok JR, Vasudevan D, Antholine WE, Thomas DD. Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases. J Biol Chem 2013;288:16004-15. Abstract/FREE Full Text
17. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 2002;53(4 Pt 1):503-14. Medline Google Scholar
18. Smith BC, Marletta MA. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol 2012;16:498-506. CrossRef Medline Google Scholar
19. Lin S, Garcia BA. Examining histone posttranslational modification patterns by high-resolution mass spectrometry. Methods Enzymol 2012;512:3-28. CrossRef Medline Google Scholar
20. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307-15. Abstract/FREE Full Text
21. Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007;35(Web Server issue):W169-75. Abstract/FREE Full Text
22. Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 2010;5:e13984. CrossRef Medline Google Scholar
23. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, et al. A travel guide to Cytoscape plugins. Nat Methods 2012;9:1069-76. CrossRef Medline Google Scholar
24. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 2014;42(Database issue):D142-7. Abstract/FREE Full Text
25. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 2004;32:1372-81. Abstract/FREE Full Text
26. Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 2014;15:703-8. Medline Google Scholar
27. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008;40:897-903. CrossRef Medline Google Scholar
28. Liu H, Kato Y, Erzinger SA, Kiriakova GM, Qian Y, Palmieri D, et al. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer 2012;12:583. CrossRef Medline Google Scholar
29. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int 2013;13:7. CrossRef Medline Google Scholar
30. Nozaki S, Sledge GW Jr., Nakshatri H. Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun 2000;275:60-2. CrossRef Medline Google Scholar
31. Mitchell A, Dass CR, Sun LQ, Khachigian LM. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res 2004;32:3065-9. Abstract/FREE Full Text
32. Chang AC, Doherty J, Huschtscha LI, Redvers R, Restall C, Reddel RR, et al. STC1 expression is associated with tumor growth and metastasis in breast cancer. Clin Exp Metastasis 2015;32:15-27. CrossRef Medline Google Scholar
33. Loss LA, Sadanandam A, Durinck S, Nautiyal S, Flaucher D, Carlton VE, et al. Prediction of epigenetically regulated genes in breast cancer cell lines. BMC Bioinformatics 2010;11:305. CrossRef Medline Google Scholar
34. Ampuja M, Jokimaki R, Juuti-Uusitalo K, Rodriguez-Martinez A, Alarmo EL, Kallioniemi A. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 2013;13:429. CrossRef Medline Google Scholar
35. Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest 2010;120:3843-54. CrossRef Medline Google Scholar
36. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011;12:7-18. CrossRef Medline Google Scholar
37. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000;5 Suppl 1:37-44. Abstract/FREE Full Text
38. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, et al. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 2010;285:8218-26. Abstract/FREE Full Text
39. Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res 2013;3:46-57. Medline Google Scholar
40. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003;2:29. CrossRef Medline Google Scholar
41. Switzer CH, Cheng RY, Ridnour LA, Glynn SA, Ambs S, Wink DA. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. Breast Cancer Res 2012;14:R125. CrossRef Medline Google Scholar
42. Boidot R, Vegran F, Jacob D, Chevrier S, Cadouot M, Feron O, et al. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene 2010;29:2577-84. CrossRef Medline Google Scholar
43. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 2012;31:1354-65. CrossRef Medline Google Scholar
44. Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, et al. Integrated genomic and epigenomic analysis of breast cancer brain metastasis. PLoS One 2014;9:e85448. CrossRef Medline Google Scholar
45. Cheng Z, Cheung P, Kuo AJ, Yukl ET, Wilmot CM, Gozani O, et al. A molecular threading mechanism underlies Jumonji lysine demethylase KDM2A regulation of methylated H3K36. Genes Dev 2014;28:1758-71. Abstract/FREE Full Text
46. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-80. Abstract/FREE Full Text
47. Garske AL, Oliver SS, Wagner EK, Musselman CA, LeRoy G, Garcia BA, et al. Combinatorial profiling of chromatin binding modules reveals multisite discrimination. Nat Chem Biol 2010;6:283-90. CrossRef Medline Google Scholar
48. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 2003;15:172-83. CrossRef Medline Google Scholar
49. Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes Dev 2013;27:1318-38. Abstract/FREE Full Text
50. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009;60:167-79. CrossRef Medline Google Scholar